, introduction of negatively charged amino acids, including aspartic acid (D) and/or E at M1, L2, C3, or L5, resulted in at least a 3-fold-reduced antibiofilm activity of OSIP108. We previously demonstrated that OSIP108 mostly localizes to the cell surface of C. albicans yeast and hyphal cells (14). The C. albicans cell surface has an overall unfavorable charge due to the presence of phosphodiester bridges within the carbohydrate side chains as well as the carboxyl groups of the cell wall proteins (15, 16). As a result, the introduction of positively charged amino acids at a variety of places within the OSIP108 sequence and removal on the negatively charged E10 could enhance the interaction of OSIP108 with its yet-unidentified cell wall target(s). Subsequent, we chosen the 5 most promising peptide analogues, i.e., these with a BIC-2 at the least 3-fold reduced than the native OSIP108, from the screening, namely, Q6R (Q6 replaced by R), G7H, G7K, G7R, and E10Y (Fig. 1; Table 1). To assess whether we could additional improve the antibiofilm activities of these OSIP108 derivatives, we combined these substitutions in double- and triplesubstituted analogues and determined the BIC-2s of these OSIP108 analogues against C. albicans biofilms (Table 1). We discovered that the antibiofilm activities of numerous double OSIP108 analogues, namely, Q6R/G7K, Q6R/G7R, and G7R/E10Y, may be additionally improved compared to the selected single-substituted OSIP108 analogues. As an example, the antibiofilm activity of Q6R/G7K was increased 8.1-fold above that of native OSIP108, whereas the Q6R and G7K single-substituted analogues had been characterized by 4.8- and 3.7-fold-increased antibiofilm activities, respectively, when compared with native OSIP108 (Table 1). Surprisingly, mixture in the improved analogue E10Y with either Q6R or G7K (leading to Q6R/E10Y and G7K/E10Y, respectively) resultedTABLE 1 Antibiofilm activities of chosen OSIP108 analogues against C.Formula of 16200-85-4 albicans biofilmsaOSIP108 analogue OSIP108 Q6R G7H G7K G7R E10Y G7-DH# G7-DK# Q6R/G7H Q6R/G7K Q6R/G7R Q6R/E10Y G7H/E10Y# G7K/E10Y G7R/E10Y* Q6R/G7H/E10Y* Q6R/G7K/E10Y Q6R/G7R/E10Y Sequence MLCVLQGLRE MLCVLRGLRE MLCVLQHLRE MLCVLQKLRE MLCVLQRLRE MLCVLQGLRY MLCVLQ(D-H)LRE MLCVLQ(D-K)LRE MLCVLRHLRE MLCVLRKLRE MLCVLRRLRE MLCVLRFLRY MLCVLQHLRY MLCVLQKLRY MLCVLQRLRY MLCVLRHLRY MLCVLRKLRY MLCVLRRLRY BIC-2 (mean 8.Price of 2869955-58-6 1 1.PMID:24856309 7 two.5 two.two 2.1 two.3 two.9 2.9 1.9 1.0 1.3 25 5.1 25 1.five 1.4 25 25 1.1 0.three 0.four 0.4 0.three 0.two 0.0 0.0 0.two 0.0 0.1 0.6 0.two 0.3 SEM) FC NA 4.eight 3.2 three.7 three.9 three.5 two.eight 2.8 four.three 8.1 6.2 NA 1.6 NA 5.four five.8 NA NAa Amino acid replacements are indicated in boldface. Analogues with paradoxical biofilm effects are indicated with an asterisk. Analogues with increased activity had been additional characterized by the fold adjust (FC) relative to OSIP108 (FC BIC-2 for OSIP108/BIC-2 OSIP108 for analogue). NA, not applicable. All peptide analogues had been statistically unique (P 0.05) in the native OSIP108 except for the analogues indicated using a pound sign.August 2014 Volume 58 Numberaac.asm.orgDelattin et al.in a total abolishment on the antibiofilm activity (Table 1; BIC-2, 25 M). Next, we assessed the antibiofilm activities in the triplesubstituted analogues Q6R/G7H/E10Y, Q6R/G7K/E10Y, and Q6R/G7R/E10Y. The antibiofilm activity of Q6R/G7H/E10Y was enhanced five.8-fold above that of native OSIP108 and hence slightly better than the corresponding single-substituted OSIP108 analogues (resulting in up to a 4.8-fold-increased antibiofilm activity in comparison with OSIP108). Two of them,.